
USD
$0.00
(0.00%
)At Close (As of Nov 28, 2025)
$2.30B
Market Cap
43.06
P/E Ratio
0.62
EPS
$27.51
52 Week High
$13.86
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $253M |
| Total Revenue | $1.2B |
| Cost Of Revenue | $914M |
| Costof Goods And Services Sold | $914M |
| Operating Income | $67M |
| Selling General And Administrative | $122M |
| Research And Development | - |
| Operating Expenses | $186M |
| Investment Income Net | - |
| Net Interest Income | $16M |
| Interest Income | $16M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.2M |
| Income Before Tax | $83M |
| Income Tax Expense | $29M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $54M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $67M |
| Ebitda | $71M |
| Net Income | $54M |
| Field | Value (USD) |
|---|---|
| Total Assets | $607M |
| Total Current Assets | $473M |
| Cash And Cash Equivalents At Carrying Value | $162M |
| Cash And Short Term Investments | $162M |
| Inventory | - |
| Current Net Receivables | $235M |
| Total Non Current Assets | $134M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $1.3M |
| Intangible Assets Excluding Goodwill | $1.3M |
| Goodwill | $16M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $66M |
| Other Current Assets | $9.4M |
| Other Non Current Assets | - |
| Total Liabilities | $185M |
| Total Current Liabilities | $169M |
| Current Accounts Payable | $95M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $2.9M |
| Total Non Current Liabilities | $16M |
| Capital Lease Obligations | $19M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $19M |
| Other Current Liabilities | $71M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $422M |
| Treasury Stock | - |
| Retained Earnings | $144M |
| Common Stock | $9K |
| Common Stock Shares Outstanding | $95M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $179M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $3.2M |
| Capital Expenditures | $5.4M |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | $196M |
| Cashflow From Financing | -$310M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$300M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $54M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $253M |
| Total Revenue | $1.2B |
| Cost Of Revenue | $914M |
| Costof Goods And Services Sold | $914M |
| Operating Income | $67M |
| Selling General And Administrative | $122M |
| Research And Development | - |
| Operating Expenses | $186M |
| Investment Income Net | - |
| Net Interest Income | $16M |
| Interest Income | $16M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.2M |
| Income Before Tax | $83M |
| Income Tax Expense | $29M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $54M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $67M |
| Ebitda | $71M |
| Net Income | $54M |
Sector: HEALTHCARE
Industry: HEALTHCARE PLANS
Progyny Inc. (PGNY) is a leading benefits management company specializing in innovative fertility and family-building solutions aimed at enhancing employee wellness for organizations across the United States. Headquartered in New York, the firm leverages advanced technology and a diverse network of fertility providers to deliver personalized support, helping employees navigate their reproductive journeys effectively. With a strong commitment to increasing access to high-quality care, Progyny not only improves health outcomes but also helps reduce healthcare costs for employers, positioning itself as a vital partner in the evolving landscape of employee health benefits. As demand for comprehensive family support continues to rise, Progyny remains at the forefront of transforming workplace benefits.